Friday, September 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Quantum eMotion Secures NYSE American Listing, Sets New Ticker

Rodolfo Hanigan by Rodolfo Hanigan
February 21, 2026
in AI & Quantum Computing, IPOs, Penny Stocks, Tech & Software
0
Quantum eMotion Stock
0
SHARES
47
VIEWS
Share on FacebookShare on Twitter

Quantum eMotion Corp. has achieved a significant corporate milestone, receiving regulatory approval to list its common shares on the NYSE American exchange. This move grants the company enhanced access to U.S. capital markets, with trading anticipated to commence imminently. Shareholders are evaluating what this transition means for their holdings.

A New Trading Venue and Symbol

The company confirmed that NYSE American LLC has granted approval for the listing and trading of its common equity. Market activity is scheduled to begin at the exchange’s opening on or about Tuesday. The shares will be traded under the new ticker symbol “QNC”.

Management has framed this uplisting as a pivotal strategic action designed to broaden its shareholder base and strengthen its profile among U.S. investors.

Transition from OTC Markets

Upon the effectiveness of the NYSE American listing, the trading of Quantum eMotion’s common stock on the OTCQB Venture Market will be terminated. The company will maintain its existing listings on two other exchanges concurrently:

Should investors sell immediately? Or is it worth buying Quantum eMotion?

  • TSX Venture Exchange (Symbol: QNC)
  • Frankfurt Stock Exchange (Symbol: 34Q0)

According to the firm’s announcement, current shareholders are not required to take any action ahead of the expected U.S. market debut. Investors who previously purchased shares via the OTCQB are advised to verify that their brokerage accounts correctly reflect the holdings under the appropriate new trading symbol.

Regulatory Pathway to the Listing

This listing follows a formal regulatory process initiated earlier this year. In January, Quantum eMotion filed a Form 40-F registration statement with U.S. authorities. This document serves as the standard method for Canadian issuers to register securities for trading on U.S. exchanges with the relevant regulators.

The immediate next step is the anticipated commencement of trading on or around Tuesday on the NYSE American platform. Concurrently, the company’s shares will cease to be quoted on the OTCQB.

Ad

Quantum eMotion Stock: Buy or Sell?! New Quantum eMotion Analysis from September 4 delivers the answer:

The latest Quantum eMotion figures speak for themselves: Urgent action needed for Quantum eMotion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 4.

Quantum eMotion: Buy or sell? Read more here...

Tags: Quantum eMotion
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

IonQ Stock
AI & Quantum Computing

IonQ Faces a Pivotal September: Warrant Expiry, Board Expansion, and a Cross-Continental Quantum Milestone

September 4, 2026
BASF Stock
Analysis

BASF’s Legal Gambit Against Apple Overshadows a Steady Week of Operational Progress

September 4, 2026
Marvell Technology Stock
Earnings

Marvell Shares Rebound as Sector Sentiment Shifts — But the Real Test Arrives in October

September 4, 2026
Next Post
Tenneco Stock

Tenneco's Indian Arm Charts a Course with Robust Orders and Strategic Moves

Community West Bancshares Stock

Leadership Shifts and Insider Buying Precede Key Merger for Community West Bancshares

Onestream Stock

Onestream Acquisition Faces Regulatory and Shareholder Scrutiny

Recommended

Vesuvius Stock

Navigating Cyclical Headwinds: Vesuvius in the Spotlight

6 months ago
Biopharmaceutical Markets and money (1)

Regeneron Pharmaceuticals Inc A Prominent Player in the Pharmaceutical Industry

3 years ago
VanEck Gold Miners ETF Stock

Gold Mining ETF Attracts Significant Investor Capital

7 months ago
Marvell Technology Stock

AI Optimism Falters as Marvell Technology’s Outlook Disappoints

12 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Infineon’s €5bn Dresden Bet and a Concluded Buyback Frame a Two-Speed Story

BASF’s Legal Gambit Against Apple Overshadows a Steady Week of Operational Progress

Arafura Rare Earths Pins Its Hopes on an October Deadline as Nolans Moves From Paper to Pickaxe

ITM Power’s Quiet Tuesday: When a Share Price Moves Without a Story

PANDION’s Insolvency Ripple Effect: Eleven Project Vehicles File as the Group’s Financial Architecture Unravels

Vanguard Widens Its All-World Franchise as Fee Cuts Keep the Cash Flowing

Trending

Hensoldt Stock
Defense & Aerospace

Hensoldt’s Dilemma: A €10 Billion Backlog That Won’t Move the Needle

by SiterGedge
September 4, 2026
0

The arithmetic at Hensoldt has stopped making sense to the market. On paper, the defence electronics group...

IonQ Stock

IonQ Faces a Pivotal September: Warrant Expiry, Board Expansion, and a Cross-Continental Quantum Milestone

September 4, 2026
ABO Energy Stock

ABO Energy’s Two-Track Rescue: Selling Off the Periphery While the Core Holds Its Breath

September 4, 2026
Infineon Stock

Infineon’s €5bn Dresden Bet and a Concluded Buyback Frame a Two-Speed Story

September 4, 2026
BASF Stock

BASF’s Legal Gambit Against Apple Overshadows a Steady Week of Operational Progress

September 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Hensoldt’s Dilemma: A €10 Billion Backlog That Won’t Move the Needle
  • IonQ Faces a Pivotal September: Warrant Expiry, Board Expansion, and a Cross-Continental Quantum Milestone
  • ABO Energy’s Two-Track Rescue: Selling Off the Periphery While the Core Holds Its Breath

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com